1-3 of 3
Hanna Janke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NPM1 Variant Allele Frequency and Outcomes in AML

Maja Rothenberg-Thurley, PhD, Tobias Herold, MD, Dennis Görlich, PhD, Cristina Sauerland, Hanna Janke, MD, Victoria V Prassek, MD, Nikola P Konstandin, PhD, Annika Maria Dufour, PhD, Stephanie Schneider, PhD, Bianka Ksienzyk, Evelyn Packeiser, Marion Subklewe, MD, Michael von Bergwelt, MD, Stefan K. Bohlander, MD, Andreas Faldum, PhD, Jan Braess, MD, Bernhard J. Wörmann, MD, Wolfgang E. Berdel, MD, Utz Krug, MD, Wolfgang Hiddemann, Karsten Spiekermann, MD, Klaus H. Metzeler, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1486.
https://doi.org/10.1182/blood-2018-99-112549
Published: 2018
Journal Articles

Activating FLT3 Mutations Display a Wide Range Of Transforming Potential and a Characteristic Pathway Profile Associated With Prognosis In Acute Myeloid Leukemia

Hanna Janke, Friederike Schneider, MD, Daniela Schumacher, Tobias Herold, MD, Hopfner Karl-Peter, PhD, Stephanie Schneider, PhD, Wolfgang E. Berdel, MD, Thomas Büchner, MD, Bernhard J. Woermann, MD, Marion Subklewe, MD, Stefan K. Bohlander, MD, Wolfgang Hiddemann, MD, Harald Polzer, PhD, Karsten Spiekermann, MD
Journal: Blood
Blood (2013) 122 (21): 1312.
https://doi.org/10.1182/blood.V122.21.1312.1312
Published: 2013
Journal Articles

CBL Deletion Mutant Found in AML Patients Cause Transformation of Receptor Tyrosine Kinase Class III Expressing Cells by Activation of the AKT Pathway

Harald Polzer, Hanna Janke, Wolfgang Hiddemann, MD, Dirk Eick, Ph.D., Karsten Spiekermann, MD
Journal: Blood
Blood (2011) 118 (21): 2447.
https://doi.org/10.1182/blood.V118.21.2447.2447
Published: 2011